1. The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib
   Annkristin Heine et al, 2016, Cancer Immunology, Immunotherapy CrossRef
2. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
   Paola De Cicco et al, 2020, Frontiers in Immunology CrossRef
3. The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer
   Hajar Alemohammad et al, 2022, Biomedicine & Pharmacotherapy CrossRef
4. Towards a Precision Medicine Approach and In Situ Vaccination against Prostate Cancer by PSMA-Retargeted oHSV
   Andrea Vannini et al, 2021, Viruses CrossRef
5. Effect of Pharmaceutical Compounds on Myeloid-Derived Suppressor Cells
   Mélanie Bruchard et al, 2018, Oncoimmunology CrossRef
6. DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy
   Cynthia Bernier et al, 2018, Anti-Cancer Drugs CrossRef
7. Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma
   Xiuqi Wu et al, 2019, Molecular Therapy CrossRef
8. Engineered nanomaterials for synergistic photo-immunotherapy
   Ranran Guo et al, 2022, Biomaterials CrossRef
9. Early T Cell Infiltration Correlates with Anti-CTLA4 Treatment Response in Murine Cancer Models
   Andrew A. Almonte et al, 2023, The Journal of Immunology CrossRef
10. Role and Therapeutic Implications of MDSCs in Sarcomas
    Brittany Lala et al, 2019, Immunotherapy of Sarcoma CrossRef
11. The Role of Myeloid Derived Suppressor Cells in Urothelial Carcinoma Immunotherapy
    Kathleen Puttmann et al, 2019, Bladder Cancer CrossRef
12. A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review
    Faezeh Sharafi et al, 2022, Cancer Cell International CrossRef
13. Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model
    Chenran Zhang et al, 2016, Biomaterials CrossRef
14. Genetics and biology of prostate cancer
    Guocan Wang et al, 2018, Genes & Development CrossRef
15. Immune checkpoint inhibitors for hepatocellular carcinoma
    Christopher E Jensen et al, 2016, Hepatic Oncology CrossRef
16. Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review
    Ling Gao et al, 2019, Frontiers in Pharmacology CrossRef
17. Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
    Chiel van Geffen et al, 2022, Frontiers in Immunology CrossRef
18. Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimen
    Yonghao Yang et al, 2017, Immunotherapy CrossRef
19. The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
    Qiyao Yang et al, 2020, Acta Pharmaceutica Sinica B CrossRef